{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:32:53Z","timestamp":1781188373864,"version":"3.54.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/P006485\/1"],"award-info":[{"award-number":["EP\/P006485\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/P006485\/1"],"award-info":[{"award-number":["EP\/P006485\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/P006485\/1"],"award-info":[{"award-number":["EP\/P006485\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/P006485\/1"],"award-info":[{"award-number":["EP\/P006485\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chimeric Antigen Receptor (CAR) T cell therapies have received increasing attention, showing promising results in the treatment of acute lymphoblastic leukaemia and aggressive B\u00a0cell lymphoma. Unlike typical cancer treatments, autologous CAR T cell therapies are patient-specific; this makes them a unique therapeutic to manufacture and distribute. In this work, we focus on the development of a computer modelling tool to assist the design and assessment of supply chain structures that can reliably and cost-efficiently deliver autologous CAR T cell therapies. We focus on four demand scales (200, 500, 1000 and 2000 patients annually) and we assess the tool\u2019s capabilities with respect to the design of responsive supply chain candidate solutions while minimising cost.<\/jats:p>","DOI":"10.1038\/s41598-022-21290-5","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T10:03:16Z","timestamp":1666000996000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A digital platform for the design of patient-centric supply chains"],"prefix":"10.1038","volume":"12","author":[{"given":"Niki","family":"Triantafyllou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Lakelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilay","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Papathanasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"21290_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21078-7","author":"JH Cho","year":"2021","unstructured":"Cho, J. H. et al. Engineering advanced logic and distributed computing in human CAR immune cells. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-021-21078-7 (2021).","journal-title":"Nat. Commun."},{"key":"21290_CR2","doi-asserted-by":"publisher","first-page":"e360","DOI":"10.14694\/EdBook_AM.2015.35.e360","volume":"35","author":"M Sadelain","year":"2015","unstructured":"Sadelain, M., Brentjens, R., Rivi\u00e8re, I. & Park, J. CD19 CAR therapy for acute lymphoblastic Leukemia. Am. Soc. Clin. Oncol. Educ. Book 35, e360\u2013e363 (2015).","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"21290_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.618427","volume":"11","author":"KJ Caldwell","year":"2021","unstructured":"Caldwell, K. J., Gottschalk, S. & Talleur, A. C. Allogeneic CAR cell therapy\u2014more than a pipe dream. Front. Immunol. 11, 1\u201312 (2021).","journal-title":"Front. Immunol."},{"key":"21290_CR4","doi-asserted-by":"crossref","unstructured":"First CAR-T therapy to target BCMA gets FDA nod. Nat. Biotechnol. 39, 531 (2021)","DOI":"10.1038\/s41587-021-00929-0"},{"key":"21290_CR5","first-page":"166","volume":"20","author":"A Mullard","year":"2021","unstructured":"Mullard, A. FDA approves fourth CAR-T cell therapy. Nat. Rev. Drug Discov. 20, 166 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"21290_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/d41573-021-00100-z","volume":"20","author":"S Upadhaya","year":"2021","unstructured":"Upadhaya, S. et al. The clinical pipeline for cancer cell therapies. Nat. Rev. Drug. Discov. 20, 503\u2013504 (2021).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"21290_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/jha2.338","volume":"3","author":"S Sengsayadeth","year":"2022","unstructured":"Sengsayadeth, S., Savani, B. N., Oluwole, O. & Dholaria, B. Overview of approved CAR-T therapies, ongoing clinical trials, and its impact on clinical practice. EJHaem 3, 6\u201310 (2022).","journal-title":"EJHaem"},{"key":"21290_CR8","first-page":"458","volume":"1","author":"A Borogovac","year":"2022","unstructured":"Borogovac, A. et al. Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: Experience from a tertiary care center. Bone Marrow Transplant. 1, 458 (2022).","journal-title":"Bone Marrow Transplant."},{"key":"21290_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/cgt.2014.78","volume":"22","author":"AD Kaiser","year":"2015","unstructured":"Kaiser, A. D. et al. Towards a commercial process for the manufacture of genetically modified T cells for therapy. Cancer Gene Ther. 22, 72\u201378 (2015).","journal-title":"Cancer Gene Ther."},{"key":"21290_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41573-021-00175-8","volume":"20","author":"CM Britten","year":"2021","unstructured":"Britten, C. M., Shalabi, A. & Hoos, A. Industrializing engineered autologous T cells as medicines for solid tumours. Nat. Rev. Drug Discov. 20, 476\u2013488 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"21290_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/cgt.2015.5","volume":"22","author":"BL Levine","year":"2015","unstructured":"Levine, B. L. Performance-enhancing drugs: Design and production of redirected chimeric antigen receptor (CAR) T cells. Cancer Gene Ther. 22, 79\u201384 (2015).","journal-title":"Cancer Gene Ther."},{"key":"21290_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.copbio.2018.01.025","volume":"53","author":"P Vormittag","year":"2018","unstructured":"Vormittag, P., Gunn, R., Ghorashian, S. & Veraitch, F. S. A guide to manufacturing CAR T cell therapies. Curr. Opin. Biotechnol. 53, 164\u2013181 (2018).","journal-title":"Curr. Opin. Biotechnol."},{"key":"21290_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jcyt.2019.01.003","volume":"21","author":"RP Harrison","year":"2019","unstructured":"Harrison, R. P., Zylberberg, E., Ellison, S. & Levine, B. L. Chimeric antigen receptor\u2013T cell therapy manufacturing: Modelling the effect of offshore production on aggregate cost of goods. Cytotherapy 21, 224\u2013233 (2019).","journal-title":"Cytotherapy"},{"key":"21290_CR14","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.drudis.2018.01.024","volume":"23","author":"B Calmels","year":"2018","unstructured":"Calmels, B., Mfarrej, B. & Chabannon, C. From clinical proof-of-concept to commercialization of CAR T cells. Drug Discov. Today 23, 758\u2013762 (2018).","journal-title":"Drug Discov. Today"},{"key":"21290_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-019-0157-z","author":"MM Papathanasiou","year":"2020","unstructured":"Papathanasiou, M. M. et al. Autologous CAR T-cell therapies supply chain: Challenges and opportunities?. Cancer Gene Ther. https:\/\/doi.org\/10.1038\/s41417-019-0157-z (2020).","journal-title":"Cancer Gene Ther."},{"key":"21290_CR16","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jcyt.2019.07.004","volume":"21","author":"RUI Li","year":"2019","unstructured":"Li, R. U. I., Johnson, R., Yu, G., McKenna, D. H. & Hubel, A. Preservation of cell-based immunotherapies for clinical trials. Cytotherapy 21, 943\u2013957 (2019).","journal-title":"Cytotherapy"},{"key":"21290_CR17","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.jcyt.2019.10.005","volume":"21","author":"S Tyagarajan","year":"2019","unstructured":"Tyagarajan, S., Schmitt, D., Acker, C. & Rutjens, E. Autologous cryopreserved leukapheresis cellular material for chimeric antigen receptor\u2013T cell manufacture. Cytotherapy 21, 1198\u20131205 (2019).","journal-title":"Cytotherapy"},{"key":"21290_CR18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.omtm.2019.11.018","volume":"16","author":"S Tyagarajan","year":"2020","unstructured":"Tyagarajan, S., Spencer, T. & Smith, J. Optimizing CAR-T cell manufacturing processes during pivotal clinical trials. Mol. Ther. Methods Clin. Dev. 16, 136\u2013144 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"21290_CR19","unstructured":"Griffiths, R. & Lakelin, M. Successfully managing the unique demands of cell therapy supply chains. 9 (2017)"},{"key":"21290_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.18609\/cgti.2016.027","volume":"2","author":"J Branke","year":"2016","unstructured":"Branke, J., Farid, S. S. & Shah, N. Industry 4.0: A vision for personalized medicine supply chains?. Cell Gene Ther. Insights 2, 263\u2013270 (2016).","journal-title":"Cell Gene Ther. Insights"},{"key":"21290_CR21","doi-asserted-by":"publisher","first-page":"655","DOI":"10.18609\/cgti.2017.067","volume":"3","author":"S Herbert","year":"2017","unstructured":"Herbert, S. Understanding the critical impact of logistics on scale-up & commercialization. Cell Gene Ther. Insights 3, 655\u2013662 (2017).","journal-title":"Cell Gene Ther. Insights"},{"key":"21290_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00482","author":"M Castella","year":"2020","unstructured":"Castella, M. et al. Point-of-care CAR T-cell production (ARI-0001) using a closed semi-automatic bioreactor: Experience from an academic phase i clinical trial. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.00482 (2020).","journal-title":"Front. Immunol."},{"key":"21290_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.573179","author":"I de Ortiz Landazuri","year":"2020","unstructured":"de Ortiz Landazuri, I. et al. Manufacturing and management of CAR T-cell therapy in \u201cCOVID-19\u2019s time\u201d: Central versus point of care proposals. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.573179 (2020).","journal-title":"Front. Immunol."},{"key":"21290_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1752592","author":"L de Macedo Abdo","year":"2020","unstructured":"de Macedo Abdo, L. et al. Development of CAR-T cell therapy for B-ALL using a point-of-care approach. OncoImmunology https:\/\/doi.org\/10.1080\/2162402X.2020.1752592 (2020).","journal-title":"OncoImmunology"},{"key":"21290_CR25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.apenergy.2015.05.090","volume":"155","author":"J Silvente","year":"2015","unstructured":"Silvente, J., Kopanos, G. M., Pistikopoulos, E. N. & Espu\u00f1a, A. A rolling horizon optimization framework for the simultaneous energy supply and demand planning in microgrids. Appl. Energy 155, 485\u2013501 (2015).","journal-title":"Appl. Energy"},{"key":"21290_CR26","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.apenergy.2018.09.159","volume":"233\u2013234","author":"S Samsatli","year":"2019","unstructured":"Samsatli, S. & Samsatli, N. J. The role of renewable hydrogen and inter-seasonal storage in decarbonising heat\u2014comprehensive optimisation of future renewable energy value chains. Appl. Energy 233\u2013234, 854\u2013893 (2019).","journal-title":"Appl. Energy"},{"key":"21290_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.apenergy.2015.01.078","volume":"147","author":"S Samsatli","year":"2015","unstructured":"Samsatli, S., Samsatli, N. J. & Shah, N. BVCM: A comprehensive and flexible toolkit for whole system biomass value chain analysis and optimisation\u2014mathematical formulation. Appl. Energy 147, 131\u2013160 (2015).","journal-title":"Appl. Energy"},{"key":"21290_CR28","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ejor.2005.02.042","volume":"174","author":"A Soylu","year":"2006","unstructured":"Soylu, A., Oru\u00e7, C., Turkay, M., Fujita, K. & Asakura, T. Synergy analysis of collaborative supply chain management in energy systems using multi-period MILP. Eur. J. Oper. Res. 174, 387\u2013403 (2006).","journal-title":"Eur. J. Oper. Res."},{"key":"21290_CR29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.apenergy.2014.10.039","volume":"138","author":"R Jokinen","year":"2015","unstructured":"Jokinen, R., Pettersson, F. & Sax\u00e9n, H. An MILP model for optimization of a small-scale LNG supply chain along a coastline. Appl. Energy 138, 423\u2013431 (2015).","journal-title":"Appl. Energy"},{"key":"21290_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.compchemeng.2019.05.004","volume":"127","author":"A Ondeck","year":"2019","unstructured":"Ondeck, A., Drouven, M., Blandino, N. & Grossmann, I. E. Multi-system shale gas supply chain planning with development and resource arrangements. Comput. Chem. Eng. 127, 49\u201370 (2019).","journal-title":"Comput. Chem. Eng."},{"key":"21290_CR31","doi-asserted-by":"publisher","first-page":"115334","DOI":"10.1016\/j.apenergy.2020.115334","volume":"274","author":"Y Ahn","year":"2020","unstructured":"Ahn, Y., Kim, J. & Kwon, J. S. I. Optimal design of supply chain network with carbon dioxide injection for enhanced shale gas recovery. Appl. Energy. 274, 115334 (2020).","journal-title":"Appl. Energy."},{"key":"21290_CR32","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1021\/acssuschemeng.5b00122","volume":"3","author":"J Gao","year":"2015","unstructured":"Gao, J. & You, F. Shale gas supply chain design and operations toward better economic and life cycle environmental performance: MINLP model and global optimization algorithm. ACS Sustain. Chem. Eng. 3, 1282\u20131291 (2015).","journal-title":"ACS Sustain. Chem. Eng."},{"key":"21290_CR33","doi-asserted-by":"publisher","first-page":"106761","DOI":"10.1016\/j.compchemeng.2020.106761","volume":"135","author":"Y Chen","year":"2020","unstructured":"Chen, Y., Cheng, X., Li, J. & He, L. A multi-level programming for shale gas-water supply chains accounting for tradeoffs between economic and environmental concerns. Comput. Chem. Eng. 135, 106761 (2020).","journal-title":"Comput. Chem. Eng."},{"key":"21290_CR34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.compchemeng.2016.03.025","volume":"92","author":"OJ Guerra","year":"2016","unstructured":"Guerra, O. J., Calder\u00f3n, A. J., Papageorgiou, L. G., Siirola, J. J. & Reklaitis, G. V. An optimization framework for the integration of water management and shale gas supply chain design. Comput. Chem. Eng. 92, 230\u2013255 (2016).","journal-title":"Comput. Chem. Eng."},{"key":"21290_CR35","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/S1570-7946(05)80040-9","volume":"20","author":"RT Sousa","year":"2005","unstructured":"Sousa, R. T., Shah, N. & Papageorgiou, L. G. Global supply chain network optimisation for pharmaceuticals. Comput. Aided Chem. Eng. 20, 1189\u20131194 (2005).","journal-title":"Comput. Aided Chem. Eng."},{"key":"21290_CR36","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1080\/00207543.2018.1504172","volume":"57","author":"SK Singh","year":"2019","unstructured":"Singh, S. K. & Goh, M. Multi-objective mixed integer programming and an application in a pharmaceutical supply chain. Int. J. Prod. Res. 57, 1214\u20131237 (2019).","journal-title":"Int. J. Prod. Res."},{"key":"21290_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-15398-4_2","volume-title":"Design and planning of sustainable vaccine supply chain","author":"MI de Carvalho","year":"2019","unstructured":"de Carvalho, M. I., Ribeiro, D. & Barbosa-Povoa, A. P. Design and planning of sustainable vaccine supply chain (Springer, Cham, 2019). https:\/\/doi.org\/10.1007\/978-3-030-15398-4_2."},{"key":"21290_CR38","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1080\/24725854.2019.1646441","volume":"52","author":"EL Tucker","year":"2020","unstructured":"Tucker, E. L., Daskin, M. S., Sweet, B. V. & Hopp, W. J. Incentivizing resilient supply chain design to prevent drug shortages: Policy analysis using two- and multi-stage stochastic programs. IISE Transactions 52, 394\u2013412 (2020).","journal-title":"IISE Transactions"},{"key":"21290_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/amp2.10025","author":"Z Kis","year":"2019","unstructured":"Kis, Z., Papathanasiou, M., Calvo-Serrano, R., Kontoravdi, C. & Shah, N. A model-based quantification of the impact of new manufacturing technologies on developing country vaccine supply chain performance: A Kenyan case study. J. Adv. Manuf. Process. https:\/\/doi.org\/10.1002\/amp2.10025 (2019).","journal-title":"J. Adv. Manuf. Process."},{"key":"21290_CR40","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.ijpe.2015.11.007","volume":"183","author":"B Fahimnia","year":"2017","unstructured":"Fahimnia, B., Jabbarzadeh, A., Ghavamifar, A. & Bell, M. Supply chain design for efficient and effective blood supply in disasters. Int. J. Prod. Econ. 183, 700\u2013709 (2017).","journal-title":"Int. J. Prod. Econ."},{"key":"21290_CR41","doi-asserted-by":"publisher","first-page":"104756","DOI":"10.1016\/j.cor.2019.07.014","volume":"112","author":"A Pirab\u00e1n","year":"2019","unstructured":"Pirab\u00e1n, A., Guerrero, W. J. & Labadie, N. Survey on blood supply chain management: Models and methods. Comput. Oper. Res. 112, 104756 (2019).","journal-title":"Comput. Oper. Res."},{"key":"21290_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.tre.2014.09.007","volume":"72","author":"B Zahiri","year":"2014","unstructured":"Zahiri, B., Tavakkoli-Moghaddam, R., Mohammadi, M. & Jula, P. Multi objective design of an organ transplant network under uncertainty. Transp. Res. E Logist. Transp. Rev. 72, 101\u2013124 (2014).","journal-title":"Transp. Res. E Logist. Transp. Rev."},{"key":"21290_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s12351-020-00568-4","volume-title":"A qualitative, patient centered perspective toward plasma products supply chain network design with risk controlling","author":"SM Hosseini-Motlagh","year":"2022","unstructured":"Hosseini-Motlagh, S. M., Gilani Larimi, N. & Oveysi Nejad, M. A qualitative, patient centered perspective toward plasma products supply chain network design with risk controlling (Operational Research Springer, Berlin Heidelberg, 2022)."},{"key":"21290_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40199-016-0144-y","volume":"24","author":"G Candan","year":"2016","unstructured":"Candan, G. & Yazgan, H. R. A novel approach for inventory problem in the pharmaceutical supply chain. DARU, J. Pharm. Sci. 24, 1\u201316 (2016).","journal-title":"DARU, J. Pharm. Sci."},{"key":"21290_CR45","doi-asserted-by":"publisher","first-page":"106913","DOI":"10.1016\/j.compchemeng.2020.106913","volume":"139","author":"P Karakostas","year":"2020","unstructured":"Karakostas, P., Panoskaltsis, N., Mantalaris, A. & Georgiadis, M. C. Optimization of CAR T-cell therapies supply chains. Comput. Chem. Eng. 139, 106913 (2020).","journal-title":"Comput. Chem. Eng."},{"key":"21290_CR46","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ejor.2021.04.057","volume":"297","author":"F Lejarza","year":"2022","unstructured":"Lejarza, F. & Baldea, M. An efficient optimization framework for tracking multiple quality attributes in supply chains of perishable products. Eur. J. Oper. Res. 297, 890\u2013903 (2022).","journal-title":"Eur. J. Oper. Res."},{"key":"21290_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpe.2013.12.028","author":"K Govindan","year":"2013","unstructured":"Govindan, K., Jafarian, A., Khodaverdi, R. & Devika, K. Two-echelon multiple-vehicle location-routing problem with time windows for optimization of sustainable supply chain network of perishable food. Int. J. Prod. Econ. https:\/\/doi.org\/10.1016\/j.ijpe.2013.12.028 (2013).","journal-title":"Int. J. Prod. Econ."},{"key":"21290_CR48","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.compchemeng.2016.02.011","volume":"91","author":"M Guo","year":"2016","unstructured":"Guo, M. et al. Implementing land-use and ecosystem service effects into an integrated bioenergy value chain optimisation framework. Comput. Chem. Eng. 91, 392\u2013406 (2016).","journal-title":"Comput. Chem. Eng."},{"key":"21290_CR49","first-page":"265","volume":"219","author":"AM Costa","year":"2014","unstructured":"Costa, A. M. et al. Sustainable vegetable crop supply problem with perishable stocks. Ann. Oper. Res. 219, 265\u2013283 (2014).","journal-title":"Ann. Oper. Res."},{"key":"21290_CR50","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10479-016-2199-z","volume":"250","author":"A Banasik","year":"2017","unstructured":"Banasik, A. et al. Assessing alternative production options for eco-efficient food supply chains using multi-objective optimization. Ann Oper Res 250, 341\u2013362 (2017).","journal-title":"Ann Oper Res"},{"key":"21290_CR51","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ijpe.2009.11.026","volume":"131","author":"A Rong","year":"2011","unstructured":"Rong, A., Akkerman, R. & Grunow, M. An optimization approach for managing fresh food quality throughout the supply chain. Int. J. Prod. Econ. 131, 421\u2013429 (2011).","journal-title":"Int. J. Prod. Econ."},{"key":"21290_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpe.2009.11.026","author":"A Rong","year":"2009","unstructured":"Rong, A., Akkerman, R. & Grunow, M. An optimization approach for managing fresh food quality throughout the supply chain. Int. J. Prod. Econ. https:\/\/doi.org\/10.1016\/j.ijpe.2009.11.026 (2009).","journal-title":"Int. J. Prod. Econ."},{"key":"21290_CR53","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1021\/ie9605490","volume":"36","author":"J Cerd\u00e1","year":"1997","unstructured":"Cerd\u00e1, J., Henning, P. G. & Grossmann, E. I. A mixed-integer linear programming model for short-term scheduling of single-stage multiproduct batch plants with parallel lines. Ind. Eng. Chem. Res. 36, 1695\u20131707 (1997).","journal-title":"Ind. Eng. Chem. Res."},{"key":"21290_CR54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0098-1354(93)80015-F","volume":"17","author":"E Kondili","year":"1993","unstructured":"Kondili, E., Pantelides, C. C. & Sargent, R. W. H. A general algorithm for short-term scheduling of batch operations\u2014I MILP formulation. Comput. Chem. Eng. 17, 211\u2013227 (1993).","journal-title":"Comput. Chem. Eng."},{"key":"21290_CR55","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1021\/ie950081l","volume":"35","author":"GL Papageorgiou","year":"1996","unstructured":"Papageorgiou, G. L. & Pantelides, C. C. Optimal campaign planning\/scheduling of multipurpose batch\/semicontinuous plants. 1. mathematical formulation. Ind. Eng. Chem. Res. 35, 488\u2013509 (1996).","journal-title":"Ind. Eng. Chem. Res."},{"key":"21290_CR56","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0098-1354(93)80016-G","volume":"17","author":"N Shah","year":"1993","unstructured":"Shah, N., Pantelides, C. C. & Sargent, R. W. H. A general algorithm for short-term scheduling of batch operations\u2014II computational issues. Comput. Chem. Eng. 17, 229\u2013244 (1993).","journal-title":"Comput. Chem. Eng."},{"key":"21290_CR57","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1021\/ie020923y","volume":"42","author":"T Maravelias","year":"2003","unstructured":"Maravelias, T. & C. & E. Grossmann, I.,. New general continuous-time state\u2212task network formulation for short-term scheduling of multipurpose batch plants. Ind. Eng. Chem. Res. 42, 3056\u20133074 (2003).","journal-title":"Ind. Eng. Chem. Res."},{"key":"21290_CR58","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1021\/ie970927g","volume":"37","author":"GM Ierapetritou","year":"1998","unstructured":"Ierapetritou, G. M. & Floudas, A. C. Effective continuous-time formulation for short-term scheduling. 1. multipurpose batch processes. Ind. Eng. Chem. Res. 37, 4341\u20134359 (1998).","journal-title":"Ind. Eng. Chem. Res."},{"key":"21290_CR59","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1021\/ie970311r","volume":"38","author":"L Mockus","year":"1998","unstructured":"Mockus, L. & Reklaitis, V. G. Continuous time representation approach to batch and continuous process scheduling. 1. MINLP formulation. Ind. Eng. Chem. Res. 38, 197\u2013203 (1998).","journal-title":"Ind. Eng. Chem. Res."},{"key":"21290_CR60","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1021\/ie010399f","volume":"41","author":"FN Giannelos","year":"2002","unstructured":"Giannelos, F. N. & Georgiadis, C. M. A simple new continuous-time formulation for short-term scheduling of multipurpose batch processes. Ind. Eng. Chem. Res. 41, 2178\u20132184 (2002).","journal-title":"Ind. Eng. Chem. Res."},{"key":"21290_CR61","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1021\/ie0100030","volume":"40","author":"P Tsiakis","year":"2001","unstructured":"Tsiakis, P., Shah, N. & Pantelides, C. C. Design of multi-echelon supply chain networks under demand uncertainty. Ind. Eng. Chem. Res. 40, 3585\u20133604 (2001).","journal-title":"Ind. Eng. Chem. Res."},{"key":"21290_CR62","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s11899-021-00635-3","volume":"16","author":"PR Geethakumari","year":"2021","unstructured":"Geethakumari, P. R., Ramasamy, D. P., Dholaria, B., Berdeja, J. & Kansagra, A. Balancing quality, cost, and access during delivery of newer cellular and immunotherapy treatments. Curr. Hematol. Malig. Rep. 16, 345\u2013356 (2021).","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"21290_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33156","author":"T Ran","year":"2020","unstructured":"Ran, T., Eichm\u00fcller, S. B., Schmidt, P. & Schlander, M. Cost of decentralized CAR T-cell production in an academic nonprofit setting. Int. J. Cancer https:\/\/doi.org\/10.1002\/ijc.33156 (2020).","journal-title":"Int. J. Cancer"},{"key":"21290_CR64","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.18609\/cgti.2018.108","volume":"4","author":"K Spink","year":"2018","unstructured":"Spink, K. & Steinsapir, A. The long road to affordability: A cost of goods analysis for an autologous CAR-T process. Cell Gene Ther. Insights 4, 1105\u20131116 (2018).","journal-title":"Cell Gene Ther. Insights"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21290-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21290-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21290-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T10:09:27Z","timestamp":1666001367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21290-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["21290"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-21290-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,17]]},"assertion":[{"value":"20 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17365"}}